2013-01-10 07:03:31 -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the
international stem cell storage company and the largest family stem cell bank in
Europe, stored 35,100 new samples in 2012 (2011: 39,900 new samples).
* 8,300 new samples stored in Q4 2012 (Q4 2011:10,300). Of these, 4,900 were
new cord blood samples and 3,400 new cord tissue samples.
* 35,100 new samples stored in 2012 (2011:39,900). Of these, 21,200 were new
cord blood samples and 13,900 new cord tissue samples.
* 239,000 samples have been stored in total at 31 December 2012.
Arnoud van Tulder, Chief Executive officer, commented:
"We are pleased to report a 35% storage growth in India compared to previous
year. This is
an immediate result from measures we implemented in India. At this
point in time this considerable growth in one of our very promising markets does
not compensate the significant decline in Southern Europe, predominantly
"We are convinced that 2013 will be a turn-around year to regain profitable
growth, as we continue to implement measures that focus on our current markets
and core services."
Please click here for full press release in PDF:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE